Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Efficacy and feasibility of aerosolized amphotericin B lipid complex therapy in caspofungin breakthrough pulmonary zygomycosis.

× No keyword cloud information.

11 in total

1. Posaconazole as salvage therapy for zygomycosis.

Authors: R N Greenberg; K Mullane; J-A H van Burik; I Raad; M J Abzug; G Anstead; R Herbrecht; A Langston; K A Marr; G Schiller; M Schuster; J R Wingard; C E Gonzalez; S G Revankar; G Corcoran; R J Kryscio; R Hare
Journal: Antimicrob Agents Chemother Date: 2006-01 Impact factor: 5.191

Review 2. Nebulized Liposomal Amphotericin B for Treatment of Pulmonary Infection Caused by Hormographiella aspergillata: Case Report and Literature Review.

Authors: Cendrine Godet; Estelle Cateau; Blandine Rammaert; Marine Grosset; Gwenaël Le Moal; Guillaume Béraud; Jean Philippe Martellosio; Xavier Iriart; Jacques Cadranel; France Roblot
Journal: Mycopathologia Date: 2017-01-31 Impact factor: 2.574

3. Inhaled antimicrobial therapies for respiratory infections.

Authors: Shin-Woo Kim; Joseph L Kuti; David P Nicolau
Journal: Curr Infect Dis Rep Date: 2008-03 Impact factor: 3.725

4. Breakthrough Candida krusei fungemia during fluconazole prophylaxis followed by breakthrough zygomycosis during caspofungin therapy in a patient with severe aplastic anemia who underwent stem cell transplantation.

Authors: Corrado Girmenia; Maria Luisa Moleti; Alessandra Micozzi; Anna Paola Iori; Walter Barberi; Robin Foà; Pietro Martino
Journal: J Clin Microbiol Date: 2005-10 Impact factor: 5.948

10. Aerosolized amphotericin B lipid complex as adjunctive treatment for fungal lung infection in patients with cancer-related immunosuppression and recipients of hematopoietic stem cell transplantation.

Authors: Amar Safdar; Gilhen H Rodriguez
Journal: Pharmacotherapy Date: 2013-06-19 Impact factor: 4.705

Efficacy and feasibility of aerosolized amphotericin B lipid complex therapy in caspofungin breakthrough pulmonary zygomycosis.

1. Posaconazole as salvage therapy for zygomycosis.

Review 2. Nebulized Liposomal Amphotericin B for Treatment of Pulmonary Infection Caused by Hormographiella aspergillata: Case Report and Literature Review.

3. Inhaled antimicrobial therapies for respiratory infections.

4. Breakthrough Candida krusei fungemia during fluconazole prophylaxis followed by breakthrough zygomycosis during caspofungin therapy in a patient with severe aplastic anemia who underwent stem cell transplantation.

Review 5. Zygomycosis: the re-emerging fungal infection.

6. Aerosolized amikacin in patients with difficult-to-treat pulmonary nontuberculous mycobacteriosis.

Review 7. Novel perspectives on mucormycosis: pathophysiology, presentation, and management.

8. Aerosolized Delivery of Antifungal Agents.

Review 9. Inhaled therapeutics for prevention and treatment of pneumonia.

10. Aerosolized amphotericin B lipid complex as adjunctive treatment for fungal lung infection in patients with cancer-related immunosuppression and recipients of hematopoietic stem cell transplantation.